Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Disease 1 Colorectal Neoplasms 1

Interventions

Magnetic Resonance Imaging 2 Cryosurgery 2 imetelstat 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 S-Adenosylmethionine 1 Prostatectomy 1 Pluvicto 1 Observation 1 Nivolumab 1 Mammography 1 High-Intensity Interval Training 1 Hematologic Tests 1 Fluorodeoxyglucose F18 1 Exercise 1 Equipment and Supplies 1 Educational Status 1 Diagnostic Techniques and Procedures 1 Diagnosis, Computer-Assisted 1 Bupivacaine 1 Blood Specimen Collection 1 Artificial Intelligence 1 Arginine 1 Acupressure 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Diagnosis, Computer-Assisted × 90 days × Clear all

NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

105 enrolled 15 charts

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡